Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Pancreatic Neoplasms 54Carcinoma, Non-Small-Cell Lung 22Neoplasms 17Neoplasm Metastasis 16Breast Neoplasms 16Triple Negative Breast Neoplasms 10Colorectal Neoplasms 9Stomach Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Ovarian Neoplasms 6Melanoma 5Carcinoma, Pancreatic Ductal 5Adenocarcinoma 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Peritoneal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Hodgkin Disease 3Fallopian Tube Neoplasms 3Carcinoma, Transitional Cell 3Urinary Bladder Neoplasms 2Solid Tumor 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Ductal Adenocarcinoma 2Nasopharyngeal Carcinoma 2

Interventions

Doxorubicin 27Cyclophosphamide 26Radiotherapy 16Gemcitabine 16Filgrastim 11pembrolizumab 10pazopanib 10Radiation 9Docetaxel 9Cisplatin 9fludarabine 7Trabectedin 7Ipilimumab 7Ifosfamide 7Granulocyte Colony-Stimulating Factor 7Etoposide 7Carboplatin 7Busulfan 7Bevacizumab 7olaratumab 6Temozolomide 6Peripheral Blood Stem Cell Transplantation 6Nivolumab 6Mesna 6Melphalan 6selinexor 5Leucovorin 5Irinotecan 5Celecoxib 5Bortezomib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma × 130-nm albumin-bound paclitaxel × Clear all
NCT05075993 2025-12-26

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
352 enrolled
DermatologicGastrointestinalGynecologicSarcoma

Uveal Melanoma, Carcinoma, Hepatocellular, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms

NCT03507491 2024-10-04

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Emory University

Phase 1 Completed
24 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡